NCT02132676

Brief Summary

The purpose of this study is to evaluate the effectiveness of a peer-to-peer program (P2P) in addition to Shared Medical Appointments (SMAs) compared to SMAs alone for the treatment of diabetes in five VA health systems, and to study the implementation process in order to gather information required to disseminate the program more broadly in the VHA system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,536

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2016

Typical duration for all trials

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2013

Completed
9 months until next milestone

First Posted

Study publicly available on registry

May 7, 2014

Completed
2 years until next milestone

Study Start

First participant enrolled

April 25, 2016

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2019

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

August 19, 2020

Completed
Last Updated

September 2, 2020

Status Verified

August 1, 2020

Enrollment Period

3.2 years

First QC Date

August 21, 2013

Results QC Date

June 30, 2020

Last Update Submit

August 19, 2020

Conditions

Keywords

Self-ManagementPatient Care ManagementPeer GroupDisease ManagementHealth Plan ImplementationDiabetes Mellitus

Outcome Measures

Primary Outcomes (1)

  • Change in Glycemic Control

    Glycemic control (measured by Hemoglobin A1c) in each group will be assessed by the comparison of an average of the values obtained during routine outpatient clinical practice in 6-month windows preceding baseline and following the 6 and 12-month post-enrollment evaluation periods. In addition to measuring absolute values of A1c, the investigators will also examine the change in the percentage of patients with an average A1c \> 8%.

    6 months and 12 months post-enrollment

Secondary Outcomes (14)

  • Change in Systolic Blood Pressure (SBP)

    6 months and 12 months post-enrollment

  • Insulin Starts

    6 months and 12 months post-enrollment

  • Emergency Department (ED) Visits

    6 months and 12 months post-enrollment

  • Statin Starts

    6 months and 12 months post-enrollment

  • Change in Number of Classes of Anti-hypertensive Meds

    6 months and 12 months post-enrollment

  • +9 more secondary outcomes

Study Arms (2)

Active treatment

All those scheduled for a Shared Medical Appointment (SMA), regardless of whether the Peer to Peer (P2P) program was offered.

Usual Care

The randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

VA outpatients with uncontrolled diabetes receiving care at a participating VA Medical Center during implementation of a P2P program for diabetes management in conjunction with SMAs

You may qualify if:

  • Veterans enrolled into diabetes Shared Medical Appointments (SMAs) at participating sites, and a random subset of those meeting criteria for diabetes SMAs who have not yet participated:
  • Veteran receiving care at a participating VA Medical Center
  • Meets at least one of the following criteria in the past 2 years;
  • at least 1 VA hospitalization with a diabetes-related International Classification Of Diseases-9 (ICD-9) code,
  • at least 2 VA outpatient visits with a diabetes-related ICD-9 code, or
  • At least 1 VA prescription for a glucose control medication (insulin or oral agent) or monitoring supplies
  • Poor glycemic control, indicated by a HbA1c in the past 6 months or:
  • at least 7.5% if age \<70, or
  • at least 8% if age 70+
  • Has a current address and telephone number listed in VA databases
  • Is competent to provide informed consent
  • Can communicate in English and by telephone
  • Able to participate in an outpatient program

You may not qualify if:

  • For no intervention control group:
  • Serious psychiatric illness (bipolar disorder, dementia, schizophrenia, or personality disorders)
  • Terminally ill
  • Prisoner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

VA Palo Alto Health Care System, Palo Alto, CA

Palo Alto, California, 94304-1290, United States

Location

VA Northern California Health Care System, Mather, CA

Sacramento, California, 95655, United States

Location

VA Connecticut Healthcare System West Haven Campus, West Haven, CT

West Haven, Connecticut, 06516, United States

Location

VA Ann Arbor Healthcare System, Ann Arbor, MI

Ann Arbor, Michigan, 48105, United States

Location

Providence VA Medical Center, Providence, RI

Providence, Rhode Island, 02908, United States

Location

Related Publications (3)

  • Heisler M, Burgess J, Cass J, Chardos JF, Guirguis AB, Jeffery SM, Strohecker LA, Tremblay AS, Wu WC, Zulman DM. The Shared Health Appointments and Reciprocal Enhanced Support (SHARES) study: study protocol for a randomized trial. Trials. 2017 May 26;18(1):239. doi: 10.1186/s13063-017-1959-7.

    PMID: 28549471BACKGROUND
  • Kowalski CP, Veeser M, Heisler M. Formative evaluation and adaptation of pre-and early implementation of diabetes shared medical appointments to maximize sustainability and adoption. BMC Fam Pract. 2018 Jul 7;19(1):109. doi: 10.1186/s12875-018-0797-3.

    PMID: 29981568BACKGROUND
  • Heisler M, Burgess J, Cass J, Chardos JF, Guirguis AB, Strohecker LA, Tremblay AS, Wu WC, Zulman DM. Evaluating the Effectiveness of Diabetes Shared Medical Appointments (SMAs) as Implemented in Five Veterans Affairs Health Systems: a Multi-site Cluster Randomized Pragmatic Trial. J Gen Intern Med. 2021 Jun;36(6):1648-1655. doi: 10.1007/s11606-020-06570-y. Epub 2021 Feb 2.

MeSH Terms

Conditions

Diabetes InsipidusDiabetes Mellitus

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPituitary DiseasesEndocrine System DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Limitations and Caveats

1. Our study sites were VAs. 2. We did not collect survey data from the usual care group, so were unable to compare responses between the two arms. 3. All clinical outcomes were gathered from EHR data gathered through clinical visits.

Results Point of Contact

Title
Dr. Michele Heisler
Organization
VA Ann Arbor Healthcare System Center for Clinical Management & Research

Study Officials

  • Mary Ellen M Heisler, MD MPA

    VA Ann Arbor Healthcare System, Ann Arbor, MI

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2013

First Posted

May 7, 2014

Study Start

April 25, 2016

Primary Completion

June 28, 2019

Study Completion

July 30, 2019

Last Updated

September 2, 2020

Results First Posted

August 19, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations